People: Merrimack Pharmaceuticals Inc (MACK.OQ)
18 Apr 2019
Ms. Jean M. Franchi has been appointed as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer of the company., effective August 21, 2017. Ms. Franchi previously served as Chief Financial Officer, Treasurer and Secretary at Dimension Therapeutics, Inc., a biotechnology company, from August 2015 to July 2017. From February 2012 to July 2015, Ms. Franchi served as Chief Financial Officer at Good Start Genetics, Inc., a molecular genetics information company. From 1995 to 2011, Ms. Franchi held various positions at Sanofi Genzyme, a global pharmaceutical company, including Senior Vice President of Corporate Finance, Senior Vice President of Business Unit Finance, Vice President of Finance and Controller, Product Line and International Group. Ms. Franchi holds a B.B.A. from Hofstra University and successfully completed the Uniform CPA Examination.
|Total Annual Compensation, USD||292,026|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||348,565|
|Fiscal Year Total, USD||640,591|